About us
- >
- About us >
- Information >
- Announcement
2019-08-01
Energenesis-Biomedical announced the implementation for “2019 Grant in collaboration with EB” since Aug 1, 2019.
Energenesis-Biomedical(EB) is the first biotech and new pharmaceutical company to fund academia together for new drug development in Taiwan. We expected the activity would enroll the huge R&D capabilities and elevate the competitiveness from academia in Taiwan. Currently, all research teams and their affiliations which been selected for funding had been signing into effect. Against this backdrop, EB announced the implantation for “2019 Grant in collaboration with EB” since Aug 1, 2019.